Novartis has launched its new multiple sclerosis injection Extavia in Europe and hopes this will lay the groundwork for an …
Cladribine, a new oral treatment for multiple sclerosis is on track for a mid-2009 filing after the release of encouraging …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

